Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 14Pancreatic Neoplasms 5Colorectal Neoplasms 3Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Biliary Tract Neoplasms 2Advanced Solid Tumors 2Advanced Non-Small Cell Lung Cancer 2Uterine Cervical Neoplasms 1Patients With Advanced or Metastatic Solid Tumors 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pan-tumor 1Neoplasm Metastasis 1Locally Advanced Gastric or Gastroesophageal Junction Cancer 1Klatskin Tumor 1Gastric Adenocarcinoma 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 11Cisplatin 10pembrolizumab 7Fluorouracil 3Drug Therapy 3spartalizumab 2derazantinib 2Leucovorin 2trametinib 1tislelizumab 1silmitasertib 1seribantumab 1pertuzumab 1olutasidenib 1galactomannan 1exatecan 1durvalumab 1becatecarin 1Tegafur 1Standard of Care 1S 1 (combination) 1Ritonavir 1Quality of Life 1Patient Reported Outcome Measures 1Oxaliplatin 1Observation 1Nivolumab 1Molecular Diagnostic Techniques 1Microscopy, Confocal 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Bile Duct Neoplasms × S 1 (combination) × Clear all
NCT06109779 2026-03-04

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

AstraZeneca

Phase 3 Active not recruiting
757 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡